Table of Contents

Select this article
- K Williams,
- J Chao,
- K Kashiwagi,
- T Masuko,
- and K Igarashi
Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.
Mol Pharmacol October 1996 50:701-708
- Abstract
- Full Text (PDF)
Select this article
- R T Bass,
- B L Buckwalter,
- B P Patel,
- M H Pausch,
- L A Price,
- J Strnad,
- and J R Hadcock
Identification and characterization of novel somatostatin antagonists.
Mol Pharmacol October 1996 50:709-715
- Abstract
- Full Text (PDF)
Select this article
- B Y Williams,
- Y Wang,
- and A Schonbrunn
Agonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites.
Mol Pharmacol October 1996 50:716-727
- Abstract
- Full Text (PDF)
Select this article
- D L Gustafson,
- H D Beall,
- E M Bolton,
- D Ross,
- and C A Waldren
Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
Mol Pharmacol October 1996 50:728-735
- Abstract
- Full Text (PDF)
Select this article
- S Itoh,
- R Lu,
- Y Bao,
- J D Morrow,
- L J Roberts,
- and V L Schuster
Structural determinants of substrates for the prostaglandin transporter PGT.
Mol Pharmacol October 1996 50:736-742; doi:10.1124/mol.50.4.736
- Abstract
- Full Text (PDF)
Select this article
- G Nickenig and
- T J Murphy
Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells.
Mol Pharmacol October 1996 50:743-751
- Abstract
- Full Text (PDF)
Select this article
- O Massot,
- J C Rousselle,
- M P Fillion,
- B Grimaldi,
- I Cloëz-Tayarani,
- A Fugelli,
- N Prudhomme,
- L Seguin,
- B Rousseau,
- M Plantefol,
- R Hen,
- and G Fillion
5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
Mol Pharmacol October 1996 50:752-762
- Abstract
- Full Text (PDF)
Select this article
- L Nie,
- H Mogami,
- M Kanzaki,
- H Shibata,
- and I Kojima
Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.
Mol Pharmacol October 1996 50:763-769
- Abstract
- Full Text (PDF)
Select this article
- Z G Wo and
- R E Oswald
Ligand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding.
Mol Pharmacol October 1996 50:770-780
- Abstract
- Full Text (PDF)
Select this article
- C Liu,
- X Zhuo,
- F J Gonzalez,
- and X Ding
Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.
Mol Pharmacol October 1996 50:781-788
- Abstract
- Full Text (PDF)
Select this article
- A P Kennedy,
- K C Mangum,
- J Linden,
- and J N Wells
Covalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe.
Mol Pharmacol October 1996 50:789-798
- Abstract
- Full Text (PDF)
Select this article
- H Canton,
- R B Emeson,
- E L Barker,
- J R Backstrom,
- J T Lu,
- M S Chang,
- and E Sanders-Bush
Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.
Mol Pharmacol October 1996 50:799-807
- Abstract
- Full Text (PDF)
Select this article
- S K Alahari,
- N M Dean,
- M H Fisher,
- R Delong,
- M Manoharan,
- K L Tivel,
- and R L Juliano
Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
Mol Pharmacol October 1996 50:808-819
- Abstract
- Full Text (PDF)
Select this article
- A Oksche,
- R Schülein,
- C Rutz,
- U Liebenhoff,
- J Dickson,
- H Müller,
- M Birnbaumer,
- and W Rosenthal
Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
Mol Pharmacol October 1996 50:820-828
- Abstract
- Full Text (PDF)
Select this article
- L A Price,
- J Strnad,
- M H Pausch,
- and J R Hadcock
Pharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway.
Mol Pharmacol October 1996 50:829-837
- Abstract
- Full Text (PDF)
Select this article
- C Sissi,
- G Capranico,
- E Menta,
- and M Palumbo
Aza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity.
Mol Pharmacol October 1996 50:838-845
- Abstract
- Full Text (PDF)
Select this article
- W E Robinson, Jr,
- M Cordeiro,
- S Abdel-Malek,
- Q Jia,
- S A Chow,
- M G Reinecke,
- and W M Mitchell
Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
Mol Pharmacol October 1996 50:846-855
- Abstract
- Full Text (PDF)
Select this article
- M C Wright,
- X J Wang,
- M Pimenta,
- V Ribeiro,
- A J Paine,
- and M C Lechner
Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.
Mol Pharmacol October 1996 50:856-863
- Abstract
- Full Text (PDF)
Select this article
- C Zhang,
- M Schmidt,
- C von Eichei-Streiber,
- and K H Jakobs
Inhibition by toxin B of inositol phosphate formation induced by G protein-coupled and tyrosine kinase receptors in N1E-115 neuroblastoma cells: involvement of Rho proteins.
Mol Pharmacol October 1996 50:864-869
- Abstract
- Full Text (PDF)
Select this article
- K S Murthy and
- G M Makhlouf
Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
Mol Pharmacol October 1996 50:870-877
- Abstract
- Full Text (PDF)
Select this article
- L Ramamoorthy,
- M C Kemp,
- and I R Tizard
Acemannan, a beta-(1,4)-acetylated mannan, induces nitric oxide production in macrophage cell line RAW 264.7.
Mol Pharmacol October 1996 50:878-884
- Abstract
- Full Text (PDF)
Select this article
- B R Conklin,
- P Herzmark,
- S Ishida,
- T A Voyno-Yasenetskaya,
- Y Sun,
- Z Farfel,
- and H R Bourne
Carboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.
Mol Pharmacol October 1996 50:885-890
- Abstract
- Full Text (PDF)
Select this article
- S Jacobitz,
- M M McLaughlin,
- G P Livi,
- M Burman,
- and T J Torphy
Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
Mol Pharmacol October 1996 50:891-899
- Abstract
- Full Text (PDF)
Select this article
- M MacFarlane,
- N A Jones,
- C Dive,
- and G M Cohen
DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.
Mol Pharmacol October 1996 50:900-911
- Abstract
- Full Text (PDF)
Select this article
- B A McCool,
- J P Pin,
- P F Brust,
- M M Harpold,
- and D M Lovinger
Functional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells.
Mol Pharmacol October 1996 50:912-922
- Abstract
- Full Text (PDF)
Select this article
- J Gomeza,
- S Mary,
- I Brabet,
- M L Parmentier,
- S Restituito,
- J Bockaert,
- and J P Pin
Coupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists.
Mol Pharmacol October 1996 50:923-930
- Abstract
- Full Text (PDF)
Select this article
- S Ueno,
- C Zorumski,
- J Bracamontes,
- and J H Steinbach
Endogenous subunits can cause ambiguities in the pharmacology of exogenous gamma-aminobutyric acidA receptors expressed in human embryonic kidney 293 cells.
Mol Pharmacol October 1996 50:931-938
- Abstract
- Full Text (PDF)
Select this article
- T M Norris,
- E Moya,
- I S Blagbrough,
- and M E Adams
Block of high-threshold calcium channels by the synthetic polyamines sFTX-3.3 and FTX-3.3.
Mol Pharmacol October 1996 50:939-946
- Abstract
- Full Text (PDF)
Select this article
- E T Piros,
- P L Prather,
- P Y Law,
- C J Evans,
- and T G Hales
Voltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors.
Mol Pharmacol October 1996 50:947-956
- Abstract
- Full Text (PDF)
Select this article
- E L Barker and
- R D Blakely
Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.
Mol Pharmacol October 1996 50:957-965
- Abstract
- Full Text (PDF)
Select this article
- V J Watts and
- K A Neve
Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
Mol Pharmacol October 1996 50:966-976
- Abstract
- Full Text (PDF)
Select this article
- S A Hjorth,
- K Thirstrup,
- and T W Schwartz
Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.
Mol Pharmacol October 1996 50:977-984
- Abstract
- Full Text (PDF)
Select this article
- M Merkouris,
- I Dragatsis,
- G Megaritis,
- G Konidakis,
- C Zioudrou,
- G Milligan,
- and Z Georgoussi
Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
Mol Pharmacol October 1996 50:985-993
- Abstract
- Full Text (PDF)
Select this article
- P A Glascott, Jr,
- M Tsyganskaya,
- E Gilfor,
- M A Zern,
- and J L Farber
The antioxidant function of the physiological content of vitamin C.
Mol Pharmacol October 1996 50:994-999
- Abstract
- Full Text (PDF)
Select this article
- S M Yu,
- S F Chen,
- Y T Lau,
- C M Yang,
- and J C Chen
Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.
Mol Pharmacol October 1996 50:1000-1009
- Abstract
- Full Text (PDF)
Select this article
- D Yu,
- L Zhang,
- J L Eiselé,
- D Bertrand,
- J P Changeux,
- and F F Weight
Ethanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor.
Mol Pharmacol October 1996 50:1010-1016
- Abstract
- Full Text (PDF)
Select this article
- K A Berg,
- S Maayani,
- and W P Clarke
5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.
Mol Pharmacol October 1996 50:1017-1023
- Abstract
- Full Text (PDF)
Select this article
- D Ragozzino,
- R M Woodward,
- Y Murata,
- F Eusebi,
- L E Overman,
- and R Miledi
Design and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.
Mol Pharmacol October 1996 50:1024-1030
- Abstract
- Full Text (PDF)
Select this article
- N Nishigaki,
- M Negishi,
- and A Ichikawa
Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.
Mol Pharmacol October 1996 50:1031-1037
- Abstract
- Full Text (PDF)
Select this article
- M Schmidt,
- C Nehls,
- U Rümenapp,
- and K H Jakobs
m3 Muscarinic receptor-induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis.
Mol Pharmacol October 1996 50:1038-1046
- Abstract
- Full Text (PDF)
Select this article
- M Komatsu,
- T Schermerhorn,
- S G Straub,
- and G W Sharp
Pituitary adenylate cyclase-activating peptide, carbachol, and glucose stimulate insulin release in the absence of an increase in intracellular Ca2+.
Mol Pharmacol October 1996 50:1047-1054
- Abstract
- Full Text (PDF)

Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.

Identification and characterization of novel somatostatin antagonists.

Agonist binding and protein kinase C activation stimulate phosphorylation of the gastrin-releasing peptide receptor at distinct sites.

Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.

Structural determinants of substrates for the prostaglandin transporter PGT.

Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells.

5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.

Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.

Ligand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding.

Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.

Covalent modification of transmembrane span III of the A1 adenosine receptor with an antagonist photoaffinity probe.

Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing.

Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.

Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.

Pharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway.

Aza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity.

Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.

Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.

Inhibition by toxin B of inositol phosphate formation induced by G protein-coupled and tyrosine kinase receptors in N1E-115 neuroblastoma cells: involvement of Rho proteins.

Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.

Acemannan, a beta-(1,4)-acetylated mannan, induces nitric oxide production in macrophage cell line RAW 264.7.

Carboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation.

Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.

DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes.

Functional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells.

Coupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists.

Endogenous subunits can cause ambiguities in the pharmacology of exogenous gamma-aminobutyric acidA receptors expressed in human embryonic kidney 293 cells.

Block of high-threshold calcium channels by the synthetic polyamines sFTX-3.3 and FTX-3.3.

Voltage-dependent inhibition of Ca2+ channels in GH3 cells by cloned mu- and delta-opioid receptors.

Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.

Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.

Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.

Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.

The antioxidant function of the physiological content of vitamin C.

Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.

Ethanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor.

5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.

Design and in vitro pharmacology of a selective gamma-aminobutyric acidC receptor antagonist.

Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.

m3 Muscarinic receptor-induced and Gi-mediated heterologous potentiation of phospholipase C stimulation: role of phosphoinositide synthesis.

Pituitary adenylate cyclase-activating peptide, carbachol, and glucose stimulate insulin release in the absence of an increase in intracellular Ca2+.

This Issue

Current Issue